Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
GLP-1 RA drugs and primary care: What do physicians need to know?
Medical Economics December 5, 2024
Key Takeaways
- GLP-1 receptor agonists effectively reduce BMI with manageable side effects and no known long-term harm, leading to high patient demand.
- These medications are reshaping physician-patient interactions, reflecting their significant impact on obesity management.
- Dr. Robert Kushner, an expert in obesity and nutrition, has extensively contributed to the field through books and scientific articles.
- His upcoming book, “Patient Centered Weight Management,” will offer healthcare professionals a comprehensive weight management program.
Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.
The new glucagon-like peptide-1 receptor agonist (GLP-1 RA) antiobesity medications have taken medicine by storm.
They work to help patients decrease their body mass index, with manageable...
Today's Sponsors
Today's Sponsor